Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
9.3K Views
•
12:42 min
•
January 7th, 2019
DOI :
January 7th, 2019
•Chapters in this video
0:04
Title
0:47
Generation of Recombinant Virus Particles
2:47
Collection and Propagation of Virus Particles
5:11
Viral Titer Evaluation
6:59
Determining Replicative and Cytotoxic Capacities of Viral Vectors Encoding Immunomodulators
8:03
Assessment of Immunological Functionality of Isolated Virus-encoded Immunomodulators from Infected Cells
10:00
Results: Evaluation of Tumor-targeted Immunomodulation by Paramyxoviruses
11:37
Conclusion
Related Videos
07:20
Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
14.7K Views
08:52
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
17.1K Views
08:51
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
9.0K Views
06:16
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
12.5K Views
07:36
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
6.3K Views
08:02
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
2.5K Views
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
3.3K Views
06:13
Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses
9.3K Views
10:13
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
8.9K Views
09:03
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
8.6K Views
Copyright © 2025 MyJoVE Corporation. All rights reserved